RTP firm to coordinate study on Covid vaccines, autoimmune disease

The study will assess the antibody response to an additional Covid-19 vaccine dose in people with an autoimmune disease who did not respond to an initial vaccine regimen.

Source: bizjournals.com Health Care:Biotechnology headlines - November 4, 2021 Category: Biotechnology Authors: Zac Ezzone Source Type: news